Pharmacoeconomics Guidelines for Malaysia March 2012

19-Apr-2012

The Pharmacoeconomic Guideline for Malaysia was launched at the 1st Pharmacoeconomic and Outcomes Research Conference 2012 held end of March in Hotel Istana.

Pharmacoeconomic analysis concerns not only the efficacy and effectiveness of new health technologies but with the costs of these technologies weighed against their benefits. Pharmacoeconomic analysis helps the decision makers of healthcare institution to optimise the limited resources in health.

For more information, please click:

Pharmacoeconomics Guidelines for Malaysia March 2012